E
E. Boullosa Graña
Publications - 6
Citations - 95
E. Boullosa Graña is an academic researcher. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 5, co-authored 5 publications receiving 87 citations.
Papers
More filters
Journal ArticleDOI
Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation.
J.M. Moreno Planas,E. Rubio González,E. Boullosa Graña,A. Garrido Botella,C. Barrios Peinado,J.L. Lucena de la Poza,M. Jiménez Garrido,V. Sánchez Turrión,V. Cuervas-Mons Martı́nez +8 more
TL;DR: In HCV cirrhotic transplanted patients the sustained virological response to combined antiviral therapy was similar to that in noncirrhotic patients, but severe adverse events including infections were much more common.
Journal ArticleDOI
Therapy of intractable pruritus with MARS.
M. Acevedo Ribó,J.M. Moreno Planas,C. Sanz Moreno,E. Rubio González,E. Rubio Gonzalez,E. Boullosa Graña,V. Sánchez-Turrión,D Sanz Guajardo,Valentín Cuervas-Mons +8 more
TL;DR: MARS is an effective treatment for intractable pruritus in cholestatic liver diseases, although its beneficial effect is short, and this extracorporeal liver device is safe, because most related adverse events are mild.
Journal ArticleDOI
Efficacy of Hepatocellular Carcinoma Locoregional Therapies on Patients Waiting for Liver Transplantation
J.M. Moreno Planas,J. López Monclús,A. Gómez Cruz,E. Rubio González,R. Pérez Arangüena,E. Boullosa Graña,A. Garcia Suarez,J.L. Pérez-Picouto,M. Fernández Ruiz,J.L. Lucena de la Poza,V. Sánchez Turrión,V. Cuervas-Mons Martı́nez +11 more
TL;DR: According to the experience, PEI and RFA are effective locoregional therapies to treat hepatocellular carcinomas of <4 cm in patients on the waiting list for liver transplantation, and their association with other techniques, such as TACE, seems adequate.
Journal ArticleDOI
Effectiveness of pegylated interferon and ribavirin in patients with liver HCV cirrhosis.
J.M. Moreno Planas,E. Rubio González,E. Boullosa Graña,M. Fernández Ruiz,M. Jiménez Garrido,J.L. Lucena de la Poza,F. Martı́nez Arrieta,C. Molina Miliani,V. Sánchez Turrión,V. Cuervas-Mons Martı́nez +9 more
TL;DR: Therapy with peginterferon and ribavirin in patients with HCV cirrhosis has a similar effectiveness to previous treatments, and a virologic response 1 month after the beginning of therapy could be a main predictor of a sustained response.
Journal ArticleDOI
Prevalence of Hepatitis C Virus Genotypes in a Spanish Liver Transplant Unit
J.M. Moreno Planas,M. Fernández Ruiz,F. Portero Azorin,E. Boullosa Graña,E. Rubio González,S. Martı́n Garcia,F. Martı́nez Arrieta,M. Jiménez Garrido,V. Sánchez Turrión,V. Cuervas-Mons Martı́nez +9 more
TL;DR: Genotype 1b, the most prevalent genotype in the authors' liver transplant unit, included older patients in whom hepatocellular carcinoma was common, perhaps due to their higher prevalence of cirrhosis, and differences in the distribution of genotypes between the population and the control group was statistically significant.